What does Lexington Biosciences, Inc. do?

Lexington Biosciences, Inc. (LXGTF) operates in the Medical - Specialties industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is LXGTF's market cap?

Lexington Biosciences, Inc. (LXGTF) has a market capitalization of approximately $379, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does LXGTF pay a dividend?

No — Lexington Biosciences, Inc. (LXGTF) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Lexington Biosciences, Inc. (LXGTF) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

LXGTF

Lexington Biosciences, Inc.

OTC·Medical, Specialties · Healthcare

$0.00$0.00+0.00%

Market cap$379.00·Aug 26 8:00 PM UTC

Price Chart

$0.00+$0.00 (+0.00%)today

−99.42%CAGR −64.29%

Select date range

FromTo

Jul 19, 2017Aug 27, 2021 → Aug 27, 2026· 5.0 yrsAug 27, 2026

Key Metrics

LXGTF does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

FinancialsFinancials Tab

RevenueC$0.00

Net Income−C$148.01K

Net Margin—

Operating Cash FlowC$0.00

Capital ExpendituresC$0.00

Free Cash FlowC$0.00

Return on Equity—

Return on Invested Capital3.4%

Net DebtC$0.00

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for LXGTF and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how LXGTF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for LXGTF and 80,000+ other tickers.

About Lexington Biosciences, Inc.

Registered Plan Private Investments Inc. operates as a private investment platform company. Its platform allows investors to use their registered plans, including registered retirement savings plans, registered education savings plans, tax-free savings accounts, registered retirement income funds, and registered disability savings plans at their direction to invest in private companies. The company was formerly known as Lexington Biosciences, Inc. and changed its name to Registered Plan Private Investments Inc. in May 2020. The company was incorporated in 2016 and is headquartered in Vancouver, Canada.

CEO: Donald Arthur McInnes
Sector: Healthcare
Industry: Medical - Specialties
Exchange: OTC
Employees: 543
Website: www.lixiangedu.com

Peers

Peers Tab

NVPLF

Nevaro Capital Corporation

Cap

$393.0

MDLM

Medley Management Inc.

Latest News

News Tab

No recent news available.

Frequently Asked Questions About LXGTF

What does Lexington Biosciences, Inc. do?: Lexington Biosciences, Inc. (LXGTF) operates in the Medical - Specialties industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is LXGTF's market cap?: Lexington Biosciences, Inc. (LXGTF) has a market capitalization of approximately $379, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does LXGTF pay a dividend?: No — Lexington Biosciences, Inc. (LXGTF) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is LXGTF profitable?: Lexington Biosciences, Inc. (LXGTF) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.